Theseus Pharmaceuticals (THRX)
US Market

Theseus Pharmaceuticals Financial Statements

Theseus Pharmaceuticals Financial Overview

Theseus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.991; its P/E ratio is -7.86; Theseus Pharmaceuticals is scheduled to report earnings on November 14, 2022, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -10.58M$ -8.66M$ -7.37M$ -6.81M$ -2.89M
EBITDA$ -10.58M$ -8.66M$ -7.37M$ -6.81M$ -2.89M
Net Income Common Stockholders$ -10.50M$ -8.66M$ -7.37M$ -6.81M$ -2.89M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 8.46M$ 90.40M$ 97.59M$ 232.04M$ 244.66M
Total Assets$ 247.50M$ 250.93M$ 97.62M$ 102.07M$ 8.61M
Total Debt$ 4.72M$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -3.74M$ -90.40M$ -97.59M$ -232.04M$ -244.66M
Total Liabilities$ 9.65M$ 4.50M$ 147.76M$ 146.14M$ 42.88M
Stockholders Equity$ 237.85M$ 246.43M$ -50.15M$ -44.07M$ -34.27M
Cash Flow
Free Cash Flow$ -7.71M$ -9.91M$ -5.32M$ -6.76M$ -1.24M
Operating Cash Flow$ -7.68M$ -9.91M$ -5.32M$ -6.76M$ -1.24M
Investing Cash Flow$ -90.70M$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ 164.17M$ -1.48M$ 1.20M$ 4.00M
Currency in USD

Theseus Pharmaceuticals Earnings and Revenue History

Theseus Pharmaceuticals Debt to Assets

Theseus Pharmaceuticals Cash Flow

Theseus Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis